At CES 2019, Medical Electronic Systems (MES) announced the availability of new features for its FDA-cleared at-home male fertility test kit.
Following the release of the YO testing app, the at-home fertility test is now available for PC platforms. Additionally, MES also introduced an all-new YO SCORE feature, as evaluated by the Cleveland Clinic and published in the Journal of Fertility and Sterility in December 2018. Within a matter of minutes, consumers are able to educate themselves and learn about their fertility potential from the comfort of their home.
A variety of at-home health kits are now available to consumers, empowering them with the ability to dive deeper into understanding everything from their fertility and genetics to potentially inform how they might better support themselves through nutrition, exercise and lifestyle changes.
At-Home Fertility Tests
MES' FDA-Approved 'YO Home Sperm' Test Now Provides a "YO SCORE"
Trend Themes
1. At-home Health Kits - Opportunity for disruptive innovation in developing more at-home health kits to empower consumers with personalized health information.
2. Digital Health Platforms - Opportunity for disruptive innovation in creating digital platforms for at-home health testing and monitoring.
3. Personalized Medicine - Opportunity for disruptive innovation in utilizing at-home health tests to provide personalized medical recommendations and treatments.
Industry Implications
1. Healthcare - Opportunity for disruptive innovation in the healthcare industry to develop and market at-home health kits.
2. Technology - Opportunity for disruptive innovation in the technology industry to create digital platforms for at-home health testing.
3. Pharmaceuticals - Opportunity for disruptive innovation in the pharmaceutical industry to utilize at-home health tests for personalized medicine.